Lidiya Didenko1 • Maaria Chaudhry2 • Kirill Alekseyev, MD, MBA3 • Mohammad Umar Farooq, MD4 • Bilal Chaudhry, MD5
Lidiya Didenko1 • Maaria Chaudhry2 • Kirill Alekseyev, MD, MBA3 • Mohammad Umar Farooq,...
A 49-year-old man presented for evaluation of a 10-year history of progressive pain in his joints. The joint pain is localized predominantly in his hands and feet.
Theodore R. Fields, MD, presents the case of a 67‑year‑old man who may soon need dialysis and who presents for follow-up of his gout and kidney disease. Can you select the best next step in the management...
Recent research may suggest that a combination of personalized treatment plus education about gout results in better treatment adherence rates in the long term. Do you agree?
The American College of Rheumatology Guideline for the Management of Gout recommends urate-lowering therapy (ULT) as first-line therapy for patients with gout. Do you know which specific therapeutic agent...
David Bursill, MD, answers our questions about the consensus statement from the Gout, Hyperuricemia and Crystal-Associated Disease Network on recommended nomenclature for disease states of gout.
Julianna Desmarais, MD, answers our questions on her new study about the efficacy and safety of anakinra in the management of acute gout and pseudogout.
